Introduction
Activation of primordial follicles is marked morphologically by the primordial-to-primary transition when the flattened granulosa cells start proliferation and become cuboidal and the oocyte grows in size. The primordial-to-primary follicle transition is a gradual process in which intermediate follicles with both flattened and cuboidal granulosa cells can be noted. Maintaining dormancy of primordial follicles on one hand, and gradual activation towards ovulation on the other, is a tightly regulated process involving several pathways (Bonnet et al., 2013; Hsueh et al., 2015; Kerr et al., 2013; Kezele and Skinner, 2003; Makker et al., 2014; Oktem and Urman, 2010; Reddy et al., 2010; Sanchez and Smitz, 2012; Skinner, 2005) . Activators (Kit ligand, FGF-2, KGF, LIF, BMP-4/7/ 15 and GDF-9) and suppressors (PTEN, Tsc1m/TORC1, FOXO3a, Fox12, p27, LHX8, FOXL2 and AMH) of the primordial-to-primary follicle transition are known to be important for its regulation. Conditional ablation of Foxo3a, Pten and Tsc1/2 in oocytes triggers increased oocyte activation (Adhikari et al., 2009 (Adhikari et al., , 2012 Reddy et al., 2008) . Also, in vitro culture of human ovarian tissue with PTEN inhibition or AKT stimulation has been shown to increase primordial follicle activation (NovellaMaestre et al., 2015) . Gene expression studies have been performed on the human fetal ovary (Fowler et al., 2009) , human mature metaphase II oocytes (Grondahl et al., 2010) , human oocytes from primordial-toprimary follicles (Markholt et al., 2012) , human pre-antral follicles (Kristensen et al., 2015) , murine embryonic gonads (Small et al., 2005) , mouse ovaries (Herrera et al., 2005) and early follicles (Dharma et al., 2009; Yoon et al., 2006) and primordial follicle assembly in rats (Nilsson et al., 2013) and sheep (Bonnet et al., 2011 (Bonnet et al., , 2013 (Bonnet et al., , 2015 . These studies have all contributed to our current knowledge on transcriptional activity governing oocyte regulation. Previously, studies on human oocytes have been performed on a pool of isolated oocytes from primordial, intermediate and primary follicles (Markholt et al., 2012) or oocytes in combination with the surrounding granulosa cells (Kristensen et al., 2015) , thus, it has not been possible to specifically dissect gene expression in oocytes from primordial and primary follicles, respectively.
The ability to induce or inhibit recruitment of dormant follicles into the growing pool and support their complete development in vivo and/or in vitro could help to address the scarcity of oocytes available for assisted reproductive technologies. This could help women with low ovarian reserve that is either physiological, i.e. due to age or pathological, e.g. due to polycystic ovarian syndrome (PCOS) or premature ovarian insufficiency (POI) (Bilgin and Kovanci, 2015; Franks and Hardy, 2010; Franks et al., 2008; Qin et al., 2015) , and women following autotransplantation after fertility cryopreservation. Insight in the molecular pathologies associated with the above mentioned conditions could potentially support research in female infertility.
In this study, we aimed to characterize and describe the transcriptome dynamics specifically associated with human oocytes from primordial and primary follicles, respectively. Using stringent statistical limits, we explored stage-specific consistently expressed genes (SSCEG) and differentially expressed genes (DEG), revealing stage-specific enrichment and dynamics in molecular pathways. Using qPCR analysis, we confirmed DEG down-regulated (FOXO1, PLCG1 and IRF6) and up-regulated (EIF4E and MDM2) as well as an equally expressed SSCEG (RPS14), in line with the RNA sequencing data. We further investigated the localization of three selected proteins (VASA, FOXO1 and EIF4E) in human ovarian tissue, and found their expression to be in coherence with the seqeuencinggenerated expression profiles of their transcripts.
Materials and Methods

Participants
Oocyte samples were obtained from ovarian cortical tissue procured from three patients who underwent unilateral oophorectomy prior to gonadotoxic treatment for a malignant disease unrelated to any ovarian malignancies. Patients were normo-ovulatory, with normal reproductive hormones, and had not received ovarian stimulation with exogenous gonadotropins. All procedures were carried out in accordance with relevant guidelines and regulations, and The Central Denmark Region Committees on Biomedical Research Ethics and the Danish Data Protection Agency approved the study. Written informed consent was obtained from all participants before inclusion. Patients consented to the research conducted. In subjects undergoing oophorectomy, a small piece of the ovarian cortex is used for evaluating the ovarian reserve and for research purposes (Danish Scientific Ethical Committee Approval Number: KF 299017 and J/KF/01/170/99) (Schmidt et al., 2003) . Ovarian cortical tissue, collected at a random time point in the menstrual cycle, was cryopreserved and catagorised as normal by morphological assessment (Rosendahl et al., 2011) . Following cryopreservation, one small piece of ovarian cortex from each patient was randomly chosen for the current study. Until use, the cortical sample was stored in liquid nitrogen (−196°C), as previously described (Andersen et al., 2008; Schmidt et al., 2004) .
Laser capture microdissection
From each of the three patients, pools of pure primordial oocytes and pools of pure primary oocytes were isolated (Fig. 1) by laser capture microdissection (LCM). The human cortical fragments, which had a size of 2×2×1 mm, were thawed and fixed by direct immersion into 4% paraformaldehyde (PFA) at 4°C for 4 h followed by dehydration and embedment in paraffin, and the embedding and sectioning was performed as previously described (Markholt et al., 2012) . During the LCM procedure, oocytes were isolated based on morphological appearance. Oocytes from primordial follicles were defined as an oocyte surrounded by 3-5 flattened pre-granulosa cells, and oocytes from primary follicles were defined as an oocyte surrounded by one layer of cuboidal granulosa cells. Care was taken to isolate the oocyte only, avoiding granulosa cell contamination of the isolates. An outline surrounding the cell of interest was marked and subsequently cut using the ultraviolet laser. Following this, the use of membrane glass slides (Arcturus ® PEN Membrane Glass Slides, Applied Biosystems, Life Technologies, Foster City, CA, USA), enabled us to lift the cell onto a sterile cap (Arcturus ® CapSure ® HS LCM Caps, Applied Biosystems, Life Technologies, Foster City, CA, USA) using infrared pulses. Isolated cells were inspected on the cap to ensure that no contamination from surrounding granulosa cells was present. Previously, good morphological distinction quality RNA in oocytes obtained from human (Markholt et al., 2012) and sheep (Bonnet et al., 2011) ovarian tissue were obtained by LCM.
RNA extraction
Total cellular RNA was extracted from the micro-dissected cells on the LCM caps using RNA isolation kit (KIT0312-l Arcturus ® Picopure ® RNA Isolation Kit, Applied Biosystems, Life Technologies, Foster City, CA, USA) according to the manufacturer's protocol. During the isolation process, RNA from the individual caps was pooled for the same patient and oocyte stage.
Library preparation and sequencing
RNA from the LCM-derived samples were converted to cDNA and subjected to linear amplification using the Ovation ® PICO SL WTA System V2 RNA amplification (#3312 NuGen Inc., San Carlos, CA, USA), and RNA-seq libraries were constructed from the output cDNA using Illumina TruSeq DNA Sample and Preparation kit (Illumina, San Diego, CA, USA), performed at AROS Applied Biotechnology, according to the manufacturer's protocol. Integrity of libraries was checked based on library yield via KAPA qPCR measurement, and Agilent Bioanalyzer 2100 peak size with a RNA 6000 Nano Lab Chip (Agilent Technologies, Santa Clare, CA, Figure 1 Experimental design for laser capture microdissection and sequencing. (A-B) Identification, laser cutting and after capture of oocytes from primordial (A) and primary (B) follicles, revealing the precision in which stage-specific oocytes were isolated. Oocytes from primordial and primary follicles, as well as granulosa cells (GC) are indicated by bars. Scale bar 50 μm. (C) Oocytes from primordial (N = 3 patients; n = 185, n = 181, n = 70 oocytes) and primary (N = 3 patients; n = 76, n = 61 = n = 45 oocytes) follicles were isolated from three different patients. Subsequently, the capadhered oocyte was lysed for mRNA isolation, cDNA synthesis and RNA sequencing. After sequencing, mapping of the data to the human genome was performed before annotation. Finally, each gene was normalized by transforming to the log2 (CPMS).
USA) at different stages of library preparation. Sequencing was performed on an Illumina HiSeq2000 platform (Illumina Inc., San Diego, CA, USA) with five random samples per lane (AROS Applied Biotechnology).
Mapping and statistical analysis
BAM files were created using Tophat (2.0.4), and Cufflinks (2.0.2) to create a list of expressed transcripts in the samples. BWA (0.6.2) was subsequently used to map all readings to the human reference genome (hg19) using the transcript list as a filter so only readings mapping to RefSeq exons (incl. non-coding RNA, and mitochondrial RNA) overlapping with expressed transcripts were used in the further analysis. Expression of each gene in a given sample was normalized and transformed to a measurement of log2 (counts per million (CPM)). Subsequently, fragments per kilobase of exon per million fragments mapped (FPKM) values were calculated on the basis of log2 (CPM), and further filtered using custom analysis in R (R Development Core Team (2015) . R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org) (Team, 2012) .
Output from statistical analysis for enrichment analysis
We extracted two main lists: SSCEG for oocytes from primordial and primary follicle transcriptomes, respectively, and DEG comparing the transcriptomes of the two morphological stages. SSCEGs were defined as genes significantly expressed (P < 0.05) in either oocytes from primordial or primary follicles, in the three different patients. SSCEG were identified using a one-sample t-test on FPKM values for each identified transcript from patient triplicates within each oocyte stage in relation to a '0' value. This in-silico merging of transcriptomes from three patients was performed to account for biological variance. DEGs were analyzed in order to investigate genes consistently down-or up-regulated during the primordial-to-primary oocyte transition. We identified DEG on the basis of genes consistently expressed in primordial-, and primary oocytes by comparing FPKM values. Significant down-or up-regulation between the FPKM values of the oocyte from the two follicle stages was defined as fold-change > 2, and/or paired t-test significance (P < 0.05) comparing gene expression between the two sets of triplicates. For the paired t-test to be performed, the transcript had to be identified in both oocyte stages. If the gene was identified in one stage only, and absent in the other, P-value was marked 'significant' and fold-change marked ∞. The transcripts in the SSCEG list were ranked based on P-value, with low P-value indicating high degree of consistency in FPKM gene expression level between patients for oocytes in the given follicular stage. The genes in the DEG lists identifying genes down-or up-regulated were ranked based on fold-change. For testing for purity of isolated oocytes, we filtered the transcript list ('Raw data', Table I -oocytes from primordial follicles, and 'Raw data', Table II-oocytes from primary follicles) (http://users-birc.au. dk/biopv/published_data/ernst_2017/) with cut-off P < 0.05 for consistency across triplicates (SSCEG), and/or FPKM value > 2.0. This filter was applied to filter out transcriptional noise in the purity analysis. The specificity of the LCM-isolated oocytes was confirmed by the presence of a number of oocyte-specific transcripts, and the absence (or low, inconsistent presence) of granulosa cell-specific transcripts (Supplementary data, Table SII ). We identified oocyte-specific transcripts such as FIGLA, DAZL, DPPA3 (STELLA), ZAR1, GDF9, DDX4 (VASA) and KIT expressed in oocytes from both primordial and primary follicles. We also noted the absence of somatic cell-specific transcripts such as FOXL2, PRDM14, AMH, KITLG, AR and CYP19A1. We detected a few somatic cell transcripts (EMX2 and LIFR in oocytes from primordial follicles and GATA4 and GLDC in oocytes from primary follicles) based on FPKM values only, however, these were not consistent across triplicates and were filtered out due to inconsistency across triplicates prior to enrichment analysis.
Biological trends
Ingenuity
® Pathways Analysis (IPA) was used to examine functional, molecular, and biological pathways enrichment for SSCEG in oocytes from primordial and primary follicles, respectively, as well as for the DEG. IPA annotates gene lists with corresponding published information (Ingenuity ® Pathways Knowledge Base) on Molecular and Cellular Function, Networks, and Pathways, in which the transcript is known to have a role (see http://www.ingenuity.com for more details). The interconnectivity between genes in a given biological network is set relative to all eligible molecules that are connected in a network according to the knowledge base. Based on this, a numeric value, a 'score', is calculated to rank the eligible genes for a given network in input dataset in relation to other networks. The network score is based on a hyper-geometric distribution and calculated via the right-tailed Fisher's Exact Test, the score being the negative log of the calculated P-value. The Molecular and Cellular Function-, and Canonical Pathway analysis identifies the IPA library functions/canonical pathways most significantly enriched in the input datasets via (1) the ratio of genes from the input dataset that map to a given function/pathway divided by the total number of genes, as listed in IPA Knowledge Base, mapping to the function/pathway, (2) a right-tailed Fischer's Exact test corrected for multiple testing (P-value < 0.05; FDR < 0.05 (Benjamin-Hochberg's test)), calculates a P-value to asses the probability that the association between genes in the dataset and the genes in the Ingenuity ® Knowledge Base for a given category/pathway is due to chance alone (IPA, QIAGEN, Redwood City, CA, USA, http:// www.qiagen.com/ingenuity).
Validation of NGS results with qPCR analysis
Total RNA was extracted from LCM-isolated cells using Arcturus ® Paradise ® Plus RNA Extraction and Isolation Kit (#KIT0312I Arcturus Bioscience Inc., Mountain View, CA, USA). Amplified cDNA was generated using the Ovation ® PICO SL WTA System V2 RNA amplification (#3312 NuGen Inc., San Carlos, CA, USA) from 5-10 ng total RNA. Predesigned and validated gene-specific TaqMan Gene Expression Assays (Applied Biosystems, Life Technologies™, Carlsbad, CA, USA) were used for real-time quantitative (q) RT-PCR. GAPDH was selected as reference gene based on existing literature (Goossens et al., 2005; Kuijk et al., 2007) . Every gene-specific TaqMan gene expression set contained genespecific exon spanning forward and reverse primers for each of the genes of interest (GAPDH (#Hs00854166_g1), EIF4E (#Hs00854166_g1), MDM2 (#Hs00540450_s1), FOXO1A (Hs01054576_m1), IRF6 (#Hs01062178_m1), PLCG1 (: Hs01008225_m1) and RPS14 (#Hs00852033_g1)) and fluorogenic MGB probes consisting of a target-specific oligonucleotide labeled with FAM™ and a non-fluorescent quencher. At least triplicate cDNA amplifications were performed in a final reaction volume of 10 μl containing 50-100 ng of cDNA, 5 μl Lightcycler ® 480
Probed Master Mix 2 × conc. (Roche, Basel, Switzerland), 0.5 μl TaqMan ® Gene Expression Assay 20Å~and nuclease free water. The PCR reactions were run in the Roche Lightcycler ® 96-well system with the following protocol: 2 sec for Uracil-DNA glycosylase enzyme activation at 50°C, 10 min DNA Polymerase activation at 95°C, and 45 cycles of 15 s denaturation at 95°C, 1 min annealing and extension at 60°C followed by a final denaturation step of 95°C over 5 min. Experiments were repeated at least three times. Triplicate expression values of each gene was set relative to the reference gene via the ΔΔC T methods (Schmittgen and Livak, 2008) . As a negative control, cDNA from no template RT-PCR reactions was used. All qPCR data was analyzed using Prism 6, version 6.0 (GraphPad Software Inc., CA, USA 
Continued
Immunofluorescence microscopy
Ovarian cortical tissue obtained from three independent patients was cut in 5 μm sections and mounted on glass slides. Rehydration and antigen retrieval was performed as described elsewhere (Stubbs et al., 2005) Continued USA) or Dako Fluorescent Mounting Medium (FOXO1, EIF4E) (Agilent Technologies, Santa Clara, CA, USA) and analyzed using a LSM510 laser-scanning confocal microscope using a 63x C-Apochromat water immersion objective NA 1.2 (Carl Zeiss, Göttingen, Germany). Zen 2011 software (Carl Zeiss, Göttingen, Germany) was used for analysis and image capturing. All immunostainings were repeated and confirmed in at least triplicates across patients.
Results
Data preparation and filtration of oocyte transcriptome data
Follicles were precisely staged based on their morphology (Fig. 1A and B) and oocytes were stringently excised using LCM, allowing the collection of pure oocytes from primordial (N = 3 patients, n = 436 oocytes) and primary (N = 3 patients, n = 182 oocytes) follicles, respectively (Table I) . Collected LCM-samples were subsequently grouped into three main samples for each stage, making a total of six samples (two from each patient), prior to library preparation and RNA sequencing ( Figs 1C and 2 ). RNA sequencing generated on average 77 million reads per sample (range: 64-110 million reads) that was mapped to the Human Genome (hg19) (average mapping: 35 million reads, range: 23-65 million reads), using RefSeq genes as the template. We log transformed expression values (Supplementary Figure S1 ) to obtain final expression values (log2(CPMS)) (Fragments Per Kilobase of Exon per million, FPKM) (Fig. 1C) .
Sorting and enrichment analysis of RNA sequencing data from oocytes from primordial and primary follicles A total of 11914 transcripts (Raw data Table I (http://users-birc.au. dk/biopv/published_data/ernst_2017/)) were found expressed in oocytes from primordial follicles and 10186 transcripts (Raw date Table II (http://users-birc.au.dk/biopv/published_data/ernst_2017/)) were noted in oocytes from primary follicles (Fig. 2) . Using a stringent one-sample t-test (P < 0.05) as statistical cut-off, a list of SSCEG was generated for oocytes from primordial and primary follicles, respectively, and selected for further analysis (Fig. 2) . The SSCEG analysis revealed 1099 transcripts (9.22%) (oocytes from primordial follicles (bold in Raw data Table I )), and 1046 transcripts (10.27%) (oocytes from primary follicles (bold in Raw data Table II) ) of the expressed genes that were significantly and consistently expressed in a stage-specific manner in oocytes from primordial and primary follicles, respectively (Fig. 2) . The SSCEG from oocytes from primordial (1099) and primary (1046) follicles were used to identify genes that were differentially expressed between the two groups. The DEG analysis identified 223 genes that were significantly down-regulated during the transition of oocytes from primordial-to-primary (highest expression in oocytes from primordial follicles) and 268 genes that were significantly upregulated (highest expression in oocytes from primary follicles) ( Fig. 2 and Supplementary Table SI) .
A heatmap of DEG FPKM data was generated to show the expression for the two different cell-stages in isolates and the correlations between the stage-specific triplicate isolates (Fig. 3) .
The specific identity of the LCM-isolated oocytes was evaluated by the presence of a number of oocyte-specific transcripts and the absence (or low, inconsistent presence) of granulosa cell-specific transcripts (Supplementary Table SII) .
Our findings were further interrogated by qPCR analysis and compared to RNA-seq data, which confirmed the findings of the tested genes. We found that the expression levels of down-regulated DEG (FOXO1, PLCG1 and IRF6) and up-regulated DEG (EIF4E and MDM2) as well as an equally expressed SSCEG (RPS14) correlated with that of the RNA sequencing data (Supplementary Figure S2) .
The pathway analysis generated enrichment analysis of the transcriptomes was performed on the following four groups: (i) SSCEG in oocytes from primordial follicles (1099 genes) (ii) SSCEG in oocytes from primary follicles (1046 genes). (iii) DEG down-regulated (223) or (iv) DEG up-regulated (268) in oocytes during the primordial-toprimary follicle transition (Fig. 2 
Global molecular profiles in oocytes from primordial follicles
In oocytes from primordial follicles, a total of 1099 SSCEG were subjected to IPA enrichment analysis, with the exception of 14 ENSMBL-IDs that remained un-mapped or filtered out during initial data uploading, thus leaving 1085 genes for further analysis. Top enriched Canonical Pathways (Table I) included 'EIF2 Signaling' (P = 5.99E-40) with high expression of genes including several members of the 'Eukaryotic Translation Initiation' group (EIF1, EIF5, EIF2S3, EIF3D, EIF3F, EIF4A2, EIF4BP2 EIF4G2), and Ribosomal Protein S6 (RPS6) (as well as several others ribosomal proteins of both type -S, and -L). Moreover, 'Regulation of eIF4 and p70S6K Signaling' (P = 3.62E-16), 'mTOR Signaling' (P = 1.62E-14) with high expression of Eukaryotic Translation Initiator 4B (EIF4B), Protein Kinase, AMPActivated, Alpha one Catalytic Subunit (PRKAA1, synonym AMPK), RPTOR Independent Companion of mTOR, complex 2 (RICTOR), and RPS6 were noted. Additionally, 'Cell Cycle: G2/M DNA Damage Checkpoint Regulation' (P = 3.34E-07) with, amongst others, consistent expression of Cyclin-Dependent Kinase 7 (CDK7), Tumor Protein 53 (TP53), Thyroid Hormone Receptor (TRIP12) and Cyclin B1 (CCBN1), and 'PPARα/RXRα Activation' (P = 1.97E-05) and 'Cyclins and Cell Cycle Regulation' (P = 2.3E-05) with consistent expression of Cyclin-Dependent Kinases 2, 6 and 7 were observed. Finally, top enriched Canonical Pathways further included 'Androgen Signaling' (P = 3.36E-05), 'CREB Signaling in Neurons' (P = 7.4E-03) and 'ERK/ MAPK Signaling' (P = 9.3E-03). The molecular network of 'ERK/ MAPK Signaling' is shown in Fig. 4A .
For detailed information on 'Molecular and Cellular Functions', 'Biological Networks' and 'Canonical Pathways', including which genes were assigned to each group in oocytes from primordial follicle SSCEG, please refer to Supplementary Table SIII.
Global molecular profiles in oocytes from primary follicles
In oocytes from primary follicles, the 1046 significant consistently expressed genes were subjected to IPA enrichment analysis. Here 11 ENSMBL-IDs remained un-mapped or filtered out during initial data uploading, thus leaving 1035 for further analysis.
Top enriched Canonical Pathways (Table I) included 'EIF2 Signaling' (P = 4.67E-55), 'Regulation of eIF4 and p70S6K Signaling' (P = 4.76E-22), 'mTOR Signaling' (P = 1.98E-17), 'HIPPO Signaling' (P = 5.2E-07) with high expression of transcripts belonging to the 'Protein Phosphatase' group (PPP1-CB,-CC,-R10, and PPP-CA, -R2A, -R2C, -R5C) as well as SMAD family member 2 (SMAD2). Further, the following pathways were found enriched 'Cell Cycle: G2/M DNA Damage Checkpoint Regulation' (P = 1.33E-06), 'Protein Kinase A Signaling' (P = 4.63E-06), 'PI3K/AKT Signaling' (P = 8.75E-05) including, amongst others the downstream effector Eukaryotic Translation Initiator 4E (EIF4E), and Heat Shock Protein 90AA1, AB1, and B1 (HSP90-AA1, -AB1, and -B1), MDM2 Proto-Oncogene E3 (MDM2), Glycogen Synthase Kinase three alpha (GSK3A), Phosphatidylinositol-4,5-Biphosphate 3-Kinase, Catalytic Subunit Beta (PIK3CB), and Forkhead Box 03 (FOXO3). Finally, top enriched Canonical Pathways further included the 'ERK5 Signaling' (P = 1.21E-04) and the 'HIPPO Signaling' (P = 5.2E-07) pathways were significantly enriched in primary oocytes. The molecular network associated with the 'HIPPO Signaling' pathway is shown in Fig. 4B .
Detailed information on 'Canonical Pathways', 'Molecular and Cellular Functions' and 'Biological Networks', including which genes were assigned to each group in oocytes from primary follicles SSCEG, is provided (Supplementary Table SIV) .
Genes down-regulated in oocytes during the primordial-to-primary transition Several Canonical Pathways were enriched in the list of downregulated genes (Table II) (noted in bold in the full enrichment listed in Supplementary Table SV) . Top Canonical Pathways included: 'Leptin Signaling in Obesity' (P = 1.98E-04) including the PLCG1 gene, 'ErbB signaling' (3.04E-03), 'PPARα/RXRα Activation' (P = 6.77E-04), 'NGF signaling' (P = 7.75E-03), 'GNRH Signaling' (1.6E-02) with downregulation of Raf-1 proto-oncogene serine/threonine kinase (RAF1), Adenylate cyclase 9 (ADCY9), nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (NFKB1). Further, 'Type II Diabetes Mellitus Signaling' (P = 4.33E-02), and 'PTEN signaling' (P = 4.8E-02) with down-regulation of FOXO1 during the primordial-to-primary transition were found. Information on 'Molecular and Cellular Functions', 'Biological Networks', and 'Canonical Pathways' are included (Supplementary Table SV) . The information on 'Regulation of eIF4, and P70S6K Signaling' category and the molecular network associated with that pathway is shown in Fig. 5A .
Genes up-regulated in oocytes during the primordial-to-primary transition
Several Canonical Pathways were enriched in the list of up-regulated genes (Table II) (noted in bold in the full enrichment listed in Supplementary Table SVI) . Top enriched Canonical Pathways upregulated during the primordial-to-primary transition included: 'EIF2 Signaling' (P = 1.92E-09), 'mTOR signaling' (P = 9.24E-04) with upregulation of EIF4E, PIK3CB, RPS5 and TSC1. Also, represented in the pathways up-regulated during the primordial-to-primary transition was the 'PI3K/AKT signaling' with transcripts Heat Shock Protein 90 AA1 (HSP90AA1), MDM2, Ras homolog enriched in brain (RHEB), EIF4E, TP53, and TSC1 which were also assigned to this pathway. Further, the following pathways, 'Regulation of eIF4, and P70S6K Signaling' (P = 3.43E-03), 'HER-2 Signaling in Breast Cancer' (P = 2.04E-02), 'FGF Signaling' (P = 2.92E-02), and 'Insulin Receptor Signaling' (P = 3.14E-02) were up-regulated during the primordial-to-primary transition.
Detailed information on 'Molecular and Cellular Functions', 'Canonical Pathways' and 'Biological Networks' is included (Supplementary Table SVI ). The 'Regulation of eIF4, and P70S6K Signaling' categories, and the molecular networks associated with these pathway are selectively noted (Fig. 5B) .
Intraovarian localization of VASA, FOXO1 and EIF4E
VASA, the gene product of DDX4 was selected for immunohistochemical staining (IHC) since DDX4 was found to be significantly expressed in both oocyte stages. The IHC showed that the VASA protein was indeed specifically present in oocytes from primordial and intermediate follicles, and absent from the surrounding somatic cells (Fig. 6A) , consistent with the SSCEG analysis. FOXO1, a member of the Figure 2 Construction of SSCEG and DEG lists. After the sequencing, mapping, annotation and filtering, as illustrated in Fig 1B, the genes (11 914 and 10 186 from oocytes from primordial and primary follicles, respectively) were filtered to include transcripts based on a t-test which selected only consistently expressed genes for each oocyte stage (1099 SSCEG and 1046 SSCEG from oocytes from primordial and primary follicles, respectively). From those SSCEG genes, DEG genes were identified (268 DEG up-regulated in oocytes from primordial-to-primary follicles and 223 DEG down-regulated in oocytes from primordial-to-primary follicles). For DEG, paired t-test P < 0.05 between two sets of triplicates and/or FPKM value fold-change >2.
Forkhead Box family, was selected due to its high expression in oocytes from primordial follicles, and low expression in oocytes from primary follicles (Supplementary Tables SI and SII) and thus, was significantly down-regulated during the primordial-to-primary transition (Supplementary Table SIII) . IHC showed the FOXO1 protein to be highly present in the nucleus of oocytes from primordial follicles, while staining was weaker and more diffusely located in the cytoplasm in activated oocytes from primary follicles (Fig. 6B and C) . The EIF4E protein is an initiator of translation of stored mRNA, and its transcript was low in oocytes from primordial follicles with a significantly higher Table SIII) . IHC using an antibody against the EIF4E protein showed very low signal in oocytes from primordial follicles whilst a stronger signal was observed in the oocyte from primary follicles ( Fig. 6D and E) , and thus, the transcript and protein levels appear coupled.
Discussion
The current study is the first that specifically and in detail describe global gene activity in human oocytes from primordial and primary follicles. We found that while, overall, some signaling pathways appear active in both oocytes stages, there are interesting differences, which might reflect key genes and pathways that are essential for maintaining follicle dormancy and primordial-to-primary transition regulation.
We found enrichment pathways previously reported to be important for dormancy/activation of resting primordial oocytes such as PI3K/AKT and mTOR signaling in both oocyte stages. Interestingly, we noted several novel factors that may be crucial for sustaining the balance between oocyte dormancy and activation during oocyte development. In the DEG analysis, we identified several candidates significantly up-or down-regulated during the primordial-to-primary transition, that may be responsible for maintenance of dormancy or for inducing activation, and subsequently, essential for female fertility.
We also assessed the intraovarian localization of gene products of selected genes as a result of the presence of their corresponding transcripts in both oocytes (VASA) or up-regulated in oocytes form primordial (FOXO1) or primary (EIF4E) follicles. We found that these gene transcripts appeared coupled to the translation product, with VASA present specifically in oocytes and absent from the surrounding somatic cells. The protein products of EIF4E and FOXO1 followed the expression of their corresponding mRNA, with the highest detection of FOXO1 in the nucleus of the oocytes from primordial follicles, and with the highest level of EIF4E in the cytoplasm of oocytes from primary follicles.
Transcriptome characteristics in oocytes from primordial and primary follicles Below, selected parts of the results are discussed in relation to reproduction, fertility and related aspects in developmental biology. Most of the selected parts are associated with 'Canonical Pathways', which can be cross-referenced to both 'Biological Networks' and 'Molecular and Cellular Functions'.
We found several pathways enriched in oocytes from both follicular stages, such as 'Estrogen Receptor Signaling', 'Germ Cell-Sertoli Cell Junction Signaling', 'Cyclins and Cell Cycle Regulation' and 'EIF2 Signaling'. The presence of the 'Estrogen Receptor Signaling' category indicates that these sex-steroid hormones are already at play in the primordial follicles probably as a results of intercellular signaling between the somatic cells and the enclosed oocyte (Knight et al., 2012) .
Specifically significantly enriched in oocytes from primary follicles were the 'Hippo Signaling' and 'ERK5 Signaling' canonical pathways. The Hippo pathway has emerged as a critical regulator of tissue growth through controlling cellular processes such as cell proliferation, death and differentiation (Hergovich, 2016) . A study on mouse oocytes and early embryos found that members of the ERK5 signaling pathway might have an important role in both meiotic and mitotic cell division (Maciejewska et al., 2011) . In human oocytes, we found the ERK5 signaling pathway to be highly significantly enriched in the primary oocyte stage, which may indicate that oocytes have begun progression towards the primary stage for meiotic cell division at the later pre-ovulatory stage.
DEG during the primordial-primary transition
Noteworthy, 'PTEN Signaling' is down-regulated during the primordial-to-primary transition and thus down-regulated upon activation of oocytes in dormant primordial follicles. This is directly in line with a rodent study that showed global follicle activation upon depletion of Pten (Reddy et al., 2008) . Loss of function of inhibitors of follicle activation, such as Tsc1, PTEN, Foxo3a, p27 and FoxL2 leads to premature activation of the primordial follicles (Adhikari et al., 2009; Castrillon et al., 2003; Rajareddy et al., 2007; Reddy et al., 2008) . The PTEN signaling pathway controls follicle activation through the Forkhead transcription factor 3A (FOXO3A). The FOXOs comprise a family of transcription factors that in the unphosphorylated state reside in the nucleus of the cell. Upon exposure to growth factors, especially those that signal via the PTEN/PI3K/AKT pathway, these transcription factors are phosphorylated and exported from the nucleus and inactivated, thereby allowing the cell to grow (Kuscu and CelikOzenci, 2015) . Indeed, genetic ablation of Foxo3a in mice increased the rate of primordial follicle activation (Castrillon et al., 2003) , resulting in oocyte death, early depletion of functional ovarian follicles, and secondary infertility.
We found FOXO3A to be SSCEG in oocytes from primary follicles, but not in oocytes from primordial follicles, which is puzzling when considering its role in primordial follicle activation. However, translational or post-translational modifications of the FOXO3A protein may render it unable to prevent progression to an oocyte in the primary follicle.
Novel to our understanding of human oocyte development, we found FOXO1 to be significantly down-regulated during the primordialto-primary transition, in line with the immunohistochemistry analysis, where we observed clear nuclear staining of FOXO1 in oocytes from primordial follicles, and weak cytoplasmic staining in oocytes in primary follicles, indicating nuclear export and subsequent inactivation upon phosphorylation. These findings suggest that FOXO1 functions in parallel with FOXO3A as an important downstream effector of the PTEN pathway in dormancy/activation of human primordial oocytes.
In the category of up-regulated Canonical Pathways in oocytes from primordial and primary follicles, notable changes included the 'mTOR Signaling' pathway and the 'PI3K/AKT Signaling' pathway, already known for their interconnected role in oocyte regulation. A key pathway implicated in the crucial roles to balance follicle growth suppression, activation and progression is the PI3K pathway (Kerr et al., 2013) . The tuberous sclerosis complex 1 (TSC1) interacts with PTEN to maintain quiescence, and the mammalian target of rapamycin (mTOR), which is an activator, is negatively regulated by TSC1 (Zheng et al., 2012) . In mutant mice lacking the Tsc1 gene in oocytes, the entire oocyte pool is activated prematurely due to elevated mTORC1 activity in the oocyte, resulting in follicular depletion and leading to premature ovarian failure (Adhikari et al., 2010) . We found TSC1 to be significantly up-regulated during the primordial-to-primary transition which may reflect that even though the oocyte is activated and initiating growth and maturation, some control of cell growth by TSC1 is needed for optimal oocyte development. Other members assigned to the 'PI3K/AKT signaling' pathway includes the molecular chaperone Heat Shock Protein 90 kDa Alpha (Cytosolic), Class A Member 1 (HSP90AA1; involved in regulation of cell cycle control and signal transduction), an isoform of the catalytic subunit of phosphoinositide 3-kinase (PI3K), PIK3CB, the proto-oncogene MDM2, and the tumor suppressor 53 (TP53). These findings support the view that control of the human primordial-to-primary transition is governed by complex inhibiting and activating factors maintaining this finely-tuned balance.
Interestingly, we found genes in the groups of the 'Regulation of eIF4 and P70S6K Signaling' pathway in both groups of DEG, however, the factors present or absent in each of the DEG groups differ noteable in the Molecular Networks, revealing the extensive molecular dynamics even within a single signaling network.
Expression of the EIF4E gene that functions in mRNA translation initiation of stored oocyte mRNAs and procession of meiosis (Henderson et al., 2009) , significantly increased during the primordialto-primary transition. Interestingly, a recent study found that EIF4A could act as an inhibitor for TORC1 upon amino acid starvation, independently of its role in translation initiation (Tsokanos et al., 2016) . Maternal mRNA and phosphorylated EIF4EBP1 variants were shown to be associated with the mouse metaphase II spindle (Romasko et al., 2013) , and pharmacological blocking of 4E-BP1 phosphorylation using the mTOR inhibitor Torin2, leads to arrest of oocyte maturation at the metaphase I stage (Mayer et al., 2014) . It is tempting to speculate that EIF4E may have a similar regulative effect on TORC1 (protein complex that contains at least mTOR and Raptor (regulatory-associated protein of TOR)) pathways during the primordial-primary transition, in addition to its role in translation initiation. An interesting approach in this regard was utilized in a pharmacological study in which transient treatment of neonatal and aged mouse ovaries with mTOR stimulators increased activation of primordial follicles (Sun et al., 2015) . In cultures of human ovarian cubes, both mTOR and/or PI3K stimulators promoted primordial follicle activation with synergistic effects of combined treatment (Sun et al., 2015) .
In summary, our data highlight possible roles of pathways not previously associated with early human follicle development.
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